CLINICAL_TRIALS
trial_result
· 2024-06-03
Clinical Trial Update: Evaluation of Treatment With Viusid in Post-COVID-19 Syndrome [NA]
Summary
A completed clinical trial evaluated Viusid for post-COVID-19 syndrome and related symptoms such as dyspnea, fatigue, cough, and inflammation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Catalysis SL | Conditions: Post-COVID-19 Syndrome, COVID-19 | NA | Status: COMPLETED